Data for (Study ST000671)

(Analysis AN001028)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4
Arachidonic acid 1.1648 1.0984 1.1320 0.6048
CL 66:1; [M-2H](2-)@6.21 1.0244 0.7758 1.1068 1.0930
CL 68:1; [M-2H](2-)@7.25 0.8760 1.2679 1.0638 0.7923
CL 70:3; [M-2H](2-)@9.51 1.1058 0.8869 0.9657 1.0416
CL 70:4; [M-2H](2-)@9.38 1.0076 1.1846 1.0361 0.7717
CL 70:5; [M-2H](2-)@9.21 1.0263 0.9617 0.8964 1.1156
CL 70:6; [M-2H](2-)@8.99 0.8238 0.9126 1.2237 1.0399
CL 70:7; [M-2H](2-)@8.79 0.9292 0.9719 0.8994 1.1995
CL 72:5; [M-2H](2-)@9.43 1.0826 1.0359 0.9216 0.9600
CL 72:6; [M-2H](2-)@9.25 1.1293 1.0612 0.9422 0.8673
CL 72:7; [M-2H](2-)@9.03 1.0916 1.0651 0.9129 0.9304
CL 72:8; [M-2H](2-)@8.86 1.0814 1.0400 0.9645 0.9141
CL 72:9; [M-2H](2-)@8.68 0.9743 0.8318 1.0349 1.1590
CL 74:11; [M-2H](2-)@8.68 0.7148 0.9522 1.1898 1.1432
CL 74:7; [M-2H](2-)@9.29 1.1562 0.8487 0.9648 1.0303
CL 74:8; [M-2H](2-)@9.14 1.0805 1.0903 0.8882 0.9410
CL 74:9; [M-2H](2-)@8.99 1.0078 1.1586 0.9191 0.9145
CL 76:11; [M-2H](2-)@8.97 0.8627 1.0528 1.1233 0.9612
CL 76:12; [M-2H](2-)@8.77 0.8996 1.0450 1.0629 0.9925
CL 78:13; [M-2H](2-)@8.85 0.9734 0.7701 1.1624 1.0941
CL 80:15; [M-2H](2-)@9.10 1.2132 1.0211 0.9820 0.7837
FFA(16:0) 1.0410 0.9916 0.9847 0.9827
FFA(18:0) 1.0249 1.0017 0.9796 0.9937
FFA(18:1) 1.1138 1.0083 0.9595 0.9184
FFA(18:2) 1.1940 1.0176 0.9206 0.8678
FFA(20:0) 1.0695 0.9790 0.9708 0.9807
FFA(20:1) 1.1027 0.9570 0.9979 0.9424
FFA(20:2) 1.1199 0.9736 1.0609 0.8456
FFA(22:0) 1.0617 0.9708 0.9521 1.0154
FFA(22:1) 1.0619 0.8950 0.9528 1.0903
FFA(22:2) 0.9792 1.1021 1.0148 0.9039
FFA(22:3) 0.7876 1.0657 1.1137 1.0330
FFA(24:0) 0.9392 1.0028 0.8928 1.1652
FFA(24:1) 1.0139 1.0102 1.0168 0.9591
lysoPE 18:0; [M-H]-@2.42 0.8259 1.0491 1.1574 0.9675
lysoPE 18:1; [M-H]-@1.78 0.8322 0.9420 0.8013 1.4245
lysoPE 20:4; [M-H]-@1.30 1.2207 0.8823 0.9019 0.9952
lysoPE 22:5; [M-H]-@1.39 1.1103 0.8917 1.1309 0.8671
lysoPE 22:6; [M-H]-@1.21 0.9644 0.8788 1.1143 1.0426
PC 30:0; [M-Ac-H]-@5.98 1.4175 0.9112 0.7776 0.8937
PC 30:1; [M-Ac-H]-@5.49 1.1950 1.0092 0.9005 0.8953
PC 31:0; [M-Ac-H]-@6.23 0.6578 1.1616 1.0262 1.1543
PC 32:0; [M-Ac-H]-@6.66 0.9767 1.2040 0.9720 0.8473
PC 32:1; [M-Ac-H]-@6.11 1.0118 0.9496 0.9551 1.0835
PC 32:2; [M-Ac-H]-@5.65 1.1378 0.9229 0.9329 1.0064
PC 33:0; [M-Ac-H]-@6.82 1.4079 0.9168 0.8796 0.7957
PC 33:1; [M-Ac-H]-@6.45 0.7124 1.1971 1.1828 0.9077
PC 33:2; [M-Ac-H]-@6.02 1.2450 0.9288 1.1791 0.6471
PC 34:1; [M-Ac-H]-@6.71 1.1013 1.1006 0.9234 0.8747
PC 34:2; [M-Ac-H]-@6.24 1.1671 0.9654 0.8665 1.0010
PC 34:3; [M-Ac-H]-@5.80 1.0370 1.0174 0.9309 1.0147
PC 35:0; [M-Ac-H]-@7.65 1.0389 0.7300 0.8466 1.3845
PC 35:2; [M-Ac-H]-@6.62 1.0972 1.0002 0.9827 0.9199
PC 35:3; [M-Ac-H]-@6.14 0.9219 1.0101 1.2469 0.8211
PC 35:4; [M-Ac-H]-@5.96 0.9329 1.1293 1.0272 0.9106
PC 35:5; [M-Ac-H]-@5.53 0.9093 0.9665 1.0618 1.0624
PC 36:0; [M-Ac-H]-@7.97 1.0105 0.8596 1.0616 1.0683
PC 36:1; [M-Ac-H]-@7.39 1.0327 1.0422 0.9499 0.9753
PC 36:2; [M-Ac-H]-@6.91 1.0672 0.9183 0.9887 1.0259
PC 36:3; [M-Ac-H]-@6.41 1.0638 1.0141 0.9748 0.9473
PC 36:4; [M-Ac-H]-@6.10 1.0017 0.9889 1.0545 0.9549
PC 37:2; [M-Ac-H]-@7.25 1.0539 0.7676 1.1217 1.0568
PC 37:4; [M-Ac-H]-@6.56 0.9633 1.0072 1.1032 0.9263
PC 37:5; [M-Ac-H]-@6.03 1.1358 0.9920 0.8995 0.9727
PC 38:2; [M-Ac-H]-@7.54 0.9708 0.8828 1.0029 1.1435
PC 38:4; [M-Ac-H]-@6.83 0.9123 0.9743 1.1392 0.9741
PC 38:5; [M-Ac-H]-@6.37 1.0929 1.1232 0.8607 0.9232
PC 38:6; [M-Ac-H]-@6.03 0.9985 1.0461 1.0246 0.9308
PC 39:6; [M-Ac-H]-@6.47 0.9795 1.1216 1.0016 0.8973
PC 40:5; [M-Ac-H]-@7.04 0.9291 1.0350 1.1080 0.9279
PC 40:6; [M-Ac-H]-@6.70 0.8282 1.0334 1.1548 0.9836
PC 40:7; [M-Ac-H]-@6.26 0.9426 0.9579 1.0803 1.0192
PC 42:10; [M-Ac-H]-@5.75 1.1323 0.9523 0.9897 0.9257
PC 42:1; [M-Ac-H]-@9.17 0.7068 0.5117 0.4075 2.3740
PC 42:8; [M-Ac-H]-@6.38 1.2248 1.2152 0.8007 0.7593
PE 32:0; [M-H]-@6.68 0.9404 1.1537 0.8520 1.0539
PE 32:1; [M-H]-@6.19 0.9712 0.7228 1.1856 1.1204
PE 33:2; [M-H]-@6.06 1.1806 1.2923 0.9075 0.6196
PE 34:0; [M-H]-@6.87 1.3469 0.9108 0.9776 0.7646
PE 34:1; [M-H]-@6.80 1.0877 0.9471 0.9135 1.0517
PE 34:2; [M-H]-@6.36 1.4304 0.9476 0.7725 0.8495
PE 34:3; [M-H]-@5.93 1.1305 1.1367 0.9361 0.7966
PE 35:2; [M-H]-@6.70 1.1853 1.0166 0.8804 0.9177
PE 36:1; [M-H]-@7.41 0.8912 1.1372 0.9294 1.0423
PE 36:2; [M-H]-@7.02 1.1528 0.9287 0.9284 0.9900
PE 36:3; [M-H]-@6.50 1.1203 1.0270 0.9194 0.9334
PE 36:5; [M-H]-@5.91 1.1782 0.9714 0.8512 0.9993
PE 36:6; [M-H]-@5.57 1.1569 0.9298 0.9808 0.9325
PE 37:2; [M-H]-@7.21 0.9502 0.9658 1.1570 0.9271
PE 37:4; [M-H]-@6.66 1.0615 1.0343 1.0003 0.9039
PE 38:2; [M-H]-@7.51 0.9716 0.7087 0.8701 1.4497
PE 38:3; [M-H]-@7.23 1.2710 0.9214 0.9499 0.8577
PE 38:4; [M-H]-@6.93 1.1037 0.9334 1.0232 0.9397
PE 38:5; [M-H]-@6.48 1.1693 0.9825 0.9868 0.8614
PE 38:6; [M-H]-@6.12 1.1193 1.0934 0.9188 0.8685
PE 38:7; [M-H]-@5.73 0.9091 1.0076 0.9817 1.1016
PE 39:4; [M-H]-@7.14 0.9576 1.0244 1.1124 0.9056
PE 39:5; [M-H]-@6.76 1.0066 1.0567 1.0642 0.8725
PE 39:6; [M-H]-@6.50 1.1208 1.1243 0.9422 0.8127
PE 39:7; [M-H]-@6.06 1.0538 1.0201 1.0509 0.8752
PE 40:5; [M-H]-@7.15 1.0425 1.1301 0.9677 0.8597
PE 40:6; [M-H]-@6.88 1.0275 1.0679 0.9622 0.9425
PE 40:7; [M-H]-@6.25 0.9283 1.0373 1.0455 0.9889
PE 40:8; [M-H]-@5.85 1.0744 1.0741 0.9574 0.8940
PE 40:9; [M-H]-@5.49 1.1383 0.9469 0.9701 0.9447
PE 41:6; [M-H]-@7.06 0.9061 0.8316 1.2406 1.0218
PE 42:7; [M-H]-@6.94 1.0478 0.9371 0.9805 1.0346
PE 42:8; [M-H]-@6.50 0.9488 1.1076 1.0166 0.9269
PE 42:9; [M-H]-@6.10 1.1911 1.0073 0.8477 0.9539
PG 32:0; [M-H]-@5.67 1.2931 0.8538 0.9355 0.9176
PG 32:1; [M-H]-@5.15 1.0435 1.0044 0.8992 1.0529
PG 33:0; [M-H]-@5.98 0.8975 0.9997 1.0376 1.0653
PG 33:1; [M-H]-@5.45 0.8679 1.0275 0.9960 1.1085
PG 34:1; [M-H]-@5.69 1.1785 1.0825 0.9401 0.7988
PG 34:2; [M-H]-@5.30 1.2362 1.0363 0.9012 0.8262
PG 35:1; [M-H]-@6.07 1.0987 1.0891 0.9979 0.8143
PG 35:2; [M-H]-@5.64 1.1615 1.0897 0.8464 0.9024
PG 36:0; [M-H]-@6.81 1.0709 0.8410 1.0995 0.9887
PG 36:1; [M-H]-@6.36 1.1172 1.0491 0.9484 0.8853
PG 36:2; [M-H]-@5.92 1.0295 0.9663 0.9711 1.0330
PG 36:3; [M-H]-@5.35 1.0237 1.0672 1.0694 0.8397
PG 36:4; [M-H]-@4.88 1.2111 1.0152 0.8455 0.9281
PG 38:2; [M-H]-@6.43 1.0467 0.9252 0.8860 1.1420
PG 38:3; [M-H]-@6.04 1.0530 0.7981 1.0389 1.1100
PG 38:4; [M-H]-@5.98 0.9144 0.9030 1.0719 1.1107
PG 38:5; [M-H]-@5.43 1.1055 0.9616 1.0796 0.8533
PG 38:6; [M-H]-@5.27 1.1009 0.9841 0.9529 0.9621
PG 40:6; [M-H]-@5.89 0.8638 1.0267 1.0615 1.0480
PG 40:7; [M-H]-@5.00 1.6810 1.0013 0.6788 0.6389
PG 40:8; [M-H]-@4.56 1.3226 1.1446 0.8009 0.7320
PG 42:10; [M-H]-@4.53 0.8572 1.5155 0.6881 0.9392
PG 44:12; [M-H]-@4.41 0.9475 1.1004 0.9584 0.9937
PI 34:1; [M-H]-@5.60 1.0200 0.9513 1.0902 0.9385
PI 34:2; [M-H]-@5.15 1.0267 0.9658 0.9264 1.0812
PI 36:2; [M-H]-@5.79 1.1303 0.9552 0.9228 0.9917
PI 36:4; [M-H]-@5.11 1.1253 0.9228 0.8850 1.0668
PI 38:2; [M-H]-@6.35 0.8600 0.7869 1.1663 1.1868
PI 38:4; [M-H]-@5.72 1.0484 0.9390 0.9967 1.0159
PI 38:5; [M-H]-@5.31 1.0322 0.9093 0.9972 1.0613
PI 38:6; [M-H]-@5.05 1.1925 0.9041 0.9042 0.9992
PI 40:4; [M-H]-@6.23 1.3570 0.8141 0.9697 0.8592
PI 40:5; [M-H]-@5.95 1.0826 0.9671 0.9732 0.9771
PI 40:6; [M-H]-@5.65 1.0392 0.8979 1.0131 1.0498
PI 40:7; [M-H]-@5.17 1.0969 0.8538 0.9881 1.0612
plasmenyl-PE 32:0; [M-H]-@7.08 1.1209 1.0427 0.8889 0.9475
plasmenyl-PE 32:1; [M-H]-@6.56 0.6218 0.8559 1.2814 1.2408
plasmenyl-PE 33:0; [M-H]-@7.35 1.2653 1.0494 0.7035 0.9818
plasmenyl-PE 34:0; [M-H]-@7.64 1.1691 1.0153 0.9950 0.8205
plasmenyl-PE 34:1; [M-H]-@7.12 0.9508 0.7218 1.0954 1.2320
plasmenyl-PE 34:2; [M-H]-@6.69 1.1798 1.0556 0.8316 0.9329
plasmenyl-PE 34:3; [M-H]-@6.33 0.9977 0.6878 0.9145 1.4000
plasmenyl-PE 35:1; [M-H]-@7.48 0.8769 0.9241 0.8125 1.3865
plasmenyl-PE 36:1; [M-H]-@7.69 0.8961 0.7252 0.6316 1.7471
plasmenyl-PE 36:3; [M-H]-@6.91 1.1836 1.0056 0.7573 1.0535
plasmenyl-PE 36:4; [M-H]-@6.64 0.9328 1.0776 0.8903 1.0993
plasmenyl-PE 36:5; [M-H]-@6.29 0.8832 1.0264 0.8333 1.2571
plasmenyl-PE 38:1; [M-H]-@8.23 0.8802 0.5913 0.7913 1.7371
plasmenyl-PE 38:2; [M-H]-@7.85 1.0485 0.7627 0.7572 1.4317
plasmenyl-PE 38:3; [M-H]-@7.53 0.9011 1.0737 0.8142 1.2110
plasmenyl-PE 38:4; [M-H]-@7.22 0.9552 0.9957 0.8943 1.1549
plasmenyl-PE 38:5; [M-H]-@6.73 1.1808 1.0464 0.8978 0.8750
plasmenyl-PE 38:6; [M-H]-@6.48 1.1316 0.9696 0.9013 0.9975
plasmenyl-PE 40:4; [M-H]-@7.72 1.1154 0.8422 1.0373 1.0052
plasmenyl-PE 40:5; [M-H]-@7.33 1.1427 1.0309 0.9854 0.8410
plasmenyl-PE 40:6; [M-H]-@7.16 1.0230 0.9431 1.0711 0.9627
plasmenyl-PE 42:6; [M-H]-@7.75 1.1645 1.0901 0.8224 0.9230
PS 38:4; [M-H]-@5.92 1.0299 0.9180 1.0395 1.0126
PS 39:6; [M-H]-@5.43 1.2739 1.0693 0.8678 0.7889
PS 40:6; [M-H]-@5.79 1.0343 0.9404 1.0835 0.9418
PS 41:6; [M-H]-@6.04 1.0238 0.9970 1.0830 0.8962
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Line:HCR | Rest/Exercise:10 minutes Exercise
F2Line:HCR | Rest/Exercise:Rest
F3Line:LCR | Rest/Exercise:10 minutes Exercise
F4Line:LCR | Rest/Exercise:Rest
  logo